Statin Trials and Goals of Cholesterol-Lowering Therapy-Reference-Cited by-同舟云学术

Statin Trials and Goals of Cholesterol-Lowering Therapy

Published:1998-04-21 Issue:15 Volume:97 Page:1436-1439
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Grundy Scott M.¹

Affiliation:

1. From the Departments of Clinical Nutrition and Internal Medicine and the Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.97.15.1436

Reference17 articles.

1. The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

2. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

3. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maximum carotid intima-media thickness and NT-pro BNP in association with retinal vein occlusion;PLOS ONE;2023-12-14

2. Dose-dependent impact of statin therapy intensity on circulating progenitor cells in patients undergoing percutaneous coronary intervention for the treatment of acute versus chronic coronary syndrome;PLOS ONE;2022-05-19

3. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway;Biomedicine & Pharmacotherapy;2019-09

4. Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein;Communications Biology;2019-05-08

5. Trials in “True” Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk;Clinical Pharmacology & Therapeutics;2019-04-29